FDA Revokes EUAs of Four COVID-19 Monoclonal Antibodies
MedPage Today) — The FDA on Friday revoked the emergency use authorizations (EUAs) of four monoclonal antibodies for COVID-19. The four drugs — bebtelovimab, sotrovimab, casirivimab/imdevimab (REGN-COV2), and tixagevimab/cilgavimab (Evusheld…
MedPage Today) — The FDA on Friday revoked the emergency use authorizations (EUAs) of four monoclonal antibodies for COVID-19.
The four drugs — bebtelovimab, sotrovimab, casirivimab/imdevimab (REGN-COV2), and tixagevimab/cilgavimab (Evusheld…
Read More
About Author
